SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
IMPAX LABORATORIES
(NQNM:IPXL Last Sale: 20.31 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (IPXL : $20.31)
$1,232 million Market Cap at September 12, 2013
Drugs SubIndustry up .00% / Health Industry up .00% Today

30831 Huntwood Avenue Research Report Earnings Snapshot - Last 11/04/18
Hayward, CA 94544 Fact Sheet
Phone: 510-476-2000 Financial Statements
Peer Comparison
Annual Reports

Larry Hsu, Pres./CEO, Arthur A. Koch Jr., CFO
Formerly GLOBAL PHARMACEUTICAL CORP (Nasdaq:GLPC). Merged with privately held Impax Pharmaceuticals, Inc. and assumed name Dec. 15, 1999.
Historical Charts    Technical Analysis
No Historical Data available for IPXL

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common IPXL $20.31 $ 0 $20.26 $20.68 318,027 $14.41 $27.25 60,657
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $1,231,944

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
01-OCT-07 IPXLE Symbol Changed to IPXL
07-APR-05 IPXL Symbol Changed to IPXLE
15-DEC-99 GLPC Symbol Changed to IPXL

A203
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex